AU4371799A - Lysine containing peptides for treatment of heart disease - Google Patents

Lysine containing peptides for treatment of heart disease

Info

Publication number
AU4371799A
AU4371799A AU43717/99A AU4371799A AU4371799A AU 4371799 A AU4371799 A AU 4371799A AU 43717/99 A AU43717/99 A AU 43717/99A AU 4371799 A AU4371799 A AU 4371799A AU 4371799 A AU4371799 A AU 4371799A
Authority
AU
Australia
Prior art keywords
peptides
present
treatment
heart disease
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43717/99A
Other languages
English (en)
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU12706/00A priority Critical patent/AU768516B2/en
Publication of AU4371799A publication Critical patent/AU4371799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU43717/99A 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease Abandoned AU4371799A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU12706/00A AU768516B2 (en) 1998-06-03 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/089,955 US5932548A (en) 1998-06-03 1998-06-03 Lysine containing peptides for treatment of heart disease
US09089955 1998-06-03
PCT/EP1999/003731 WO1999062539A1 (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU12706/00A Division AU768516B2 (en) 1998-06-03 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Publications (1)

Publication Number Publication Date
AU4371799A true AU4371799A (en) 1999-12-20

Family

ID=22220375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43717/99A Abandoned AU4371799A (en) 1998-06-03 1999-05-28 Lysine containing peptides for treatment of heart disease

Country Status (11)

Country Link
US (1) US5932548A (enExample)
EP (2) EP1616571A3 (enExample)
JP (1) JP2002516872A (enExample)
AT (1) ATE314083T1 (enExample)
AU (1) AU4371799A (enExample)
CA (1) CA2330567A1 (enExample)
DE (1) DE69929188T2 (enExample)
DK (1) DK1082128T3 (enExample)
ES (1) ES2259834T3 (enExample)
PT (1) PT1082128E (enExample)
WO (1) WO1999062539A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024770A2 (en) 1998-10-23 2000-05-04 Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
JP3498041B2 (ja) * 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
EP1297839A4 (en) * 2000-06-23 2005-12-07 Kaken Pharma Co Ltd PREVENTIVA OR THERAPEUTIC AGAINST HEART FAILURE
AU2002354951A1 (en) * 2001-07-19 2003-03-03 Dmi Biosciences, Inc. Use of copper chelators to inhibit the inactivation of protein c
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
US20050002876A1 (en) * 2003-05-07 2005-01-06 Yukl Richard L. Oral care methods and products
AU2005289685B2 (en) 2004-09-24 2009-07-16 Amgen Inc. Modified Fc molecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
GB0603295D0 (en) 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
JO3324B1 (ar) 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
US8536120B2 (en) * 2006-04-28 2013-09-17 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP2898900B1 (en) 2008-09-19 2017-11-15 Nektar Therapeutics Polymer conjugates of ziconotide
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
DK0783521T3 (da) * 1994-09-27 2003-01-27 Ardana Bioscience Ltd Polypeptidforbindelser indeholdende D-2-alkyltryptophan, hvilke er i stand til at fremme frigivelsen af væksthormon
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
SE9703929D0 (sv) * 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutical use and method
US5798102A (en) * 1997-03-04 1998-08-25 Milkhaus Laboratory, Inc. Treatment of cardiomyopathy
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
JP2002516872A (ja) 2002-06-11
WO1999062539A1 (en) 1999-12-09
EP1616571A2 (en) 2006-01-18
DE69929188T2 (de) 2006-08-17
EP1082128A1 (en) 2001-03-14
ATE314083T1 (de) 2006-01-15
DK1082128T3 (da) 2006-04-10
PT1082128E (pt) 2006-05-31
CA2330567A1 (en) 1999-12-09
HK1035863A1 (en) 2001-12-14
US5932548A (en) 1999-08-03
EP1082128B1 (en) 2005-12-28
ES2259834T3 (es) 2006-10-16
EP1616571A3 (en) 2008-08-13
DE69929188D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
AU4371799A (en) Lysine containing peptides for treatment of heart disease
CA1330037C (en) Treatment of cancer with somatostatin and analogs thereof
US6225444B1 (en) Neuroprotective peptides and uses thereof
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
AR002024A1 (es) Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas.
CA2022437A1 (en) Reduced size lhrh analogs
CA2064689A1 (en) Stabilized protein or peptide conjugates
HUP9901069A2 (hu) Az eritropoietin receptorhoz kötődő vegyületek és peptidek
US6025471A (en) Diazaspiro, azepino and azabicyclo therapeutic peptides
KR102345605B1 (ko) 에리스로포이에틴 유래 펩티드의 세포손상방지에 효과를 통한 활용
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO2000021548A3 (en) Angiogenically effective unit dose of fgf and method of administering
JPH10509428A (ja) 活性依存性神経栄養因子の神経栄養ペプチド
KR100286242B1 (ko) 돌라스타틴 유도체
HUE026150T2 (en) Inhibitors of apoptosis and uses thereof
EP0546068A1 (en) Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
EP3966226B1 (en) Masp inhibitory compounds and uses thereof
US4684624A (en) Method of treating cerebral ischemia
KR880012641A (ko) 아미노산 유도체
HU198512B (en) Process for producing peptide with anticoagulant effect and pharmaceutical composition comprising same
KR100555604B1 (ko) 탁산과 조합된 돌라스태틴-15 유도체
WO1998031705A1 (en) Bromo-tryptophan conopeptides
ES2382992T3 (es) Antagonistas de la proteína morfogenética ósea basados en la proteína madura
EA007841B1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
CA2290739A1 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase